Enveda makes ‘exercise pill’ that skips the treadmill
Drug mimics a hormone you make when you push hard at the gym – early results suggest it…
Amylyx endocrine drug succeeds in key study for low blood sugar
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Enveda weight loss maintenance pill mimics exercise in early tests
If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
From GLP-1 hormone to weight-loss drug: How semaglutide is made and why quality matters
What does it really take to recreate one of today’s most talked-about medicines? As semaglutide gains traction worldwide,…
Eli Lilly to offer retatrutide access given earlier to just one patient
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
Compounded GLP-1s: Why doctors worry and the FDA is cracking down
So, are these copycat versions of the weight loss drugs safe? Poison control centers across the U.S. have…
How AI is supercharging drug development
Illustration: Aïda Amer/Axios. Stock: Getty Images Artificial intelligence is dramatically speeding up drug development — and a proprietary…
Scientists’ Side Hustle? Using AI and Quantum Computing to Generate New Peptides
Scientists have successfully shown a quantum computer can improve the accuracy and reach of generative artificial intelligence drug…
Calico targets longevity pathway with rare disease win
FDA Breakthrough Therapy Designation for fosigotifator highlights a mechanism that extends well beyond an ultra-rare childhood disorder. Calico…
China, Shanghai, AI hair growth drug, Eli Lilly: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
Definium LSD therapy for major depression helped patients in Phase 3 trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Industry and regulators signal a smarter, collaborative era for supplement oversight
While the industry has spent years bracing for and fending off a heavier regulatory hand, what it heard…